A Long-term Follow-up Study of Botulinum Toxin Type A in Patients With Overactive Bladder as a Result of Spinal Injury or Multiple Sclerosis

Inclusion Criteria:

Patient has participated in study 191622-515 or 191622-516 and the following criteria fulfilled:

Patient completed at least 52 weeks in the preceding study.
No longer than 6 months has elapsed since completion of the preceding study
Patient has not received any prohibited medications during any intervening period between the preceding study and this long-term study.

Exclusion Criteria:

History or evidence of pelvic or urologic abnormality.
Previous or current diagnosis of bladder or prostate cancer.